Cancer-drug discovery and cardiovascular surveillance. Groarke JD, Cheng S, Moslehi J (2013) N Engl J Med 369: 1779-81 High-dose non-steroidal anti-inflammatories: painful choices. Griffin MR (2013) Lancet 382: 746-8 Report of the Task Force on Vascular Medicine. Shepherd JT, Bergan JJ, Cohen RA, Hawiger JJ, Hillis LD, Katzen BT, Mohr JP (1994) Circulation 89: 532-5 Percutaneous vascular stent implantation as treatment for central vascular obstruction due to fibrosing mediastinitis. Albers EL, Pugh ME, Hill KD, Wang L, Loyd JE, Doyle TP (2011) Circulation 123: 1391-9 Outcome in medically treated coronary artery disease. Ischemic events: nonfatal infarction and death. Harris PJ, Lee KL, Harrell FE, Behar VS, Rosati RA (1980) Circulation 62: 718-26 The vascular depression hypothesis: mechanisms linking vascular disease with depression. Taylor WD, Aizenstein HJ, Alexopoulos GS (2013) Mol Psychiatry 18: 963-74 Perspectives on the Management of Vascular Depression. Taylor WD, Schultz SK, Panaite V, Steffens DC (2018) Am J Psychiatry 175: 1169-1175 Sickle cell disease, vasculopathy, and therapeutics. Kassim AA, DeBaun MR (2013) Annu Rev Med 64: 451-66 Cardiovascular complications of radiation therapy for thoracic malignancies: the role for non-invasive imaging for detection of cardiovascular disease. Groarke JD, Nguyen PL, Nohria A, Ferrari R, Cheng S, Moslehi J (2014) Eur Heart J 35: 612-23 Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG (2007) J Exp Med 204: 2449-60 From ST segments to endothelial pathophysiology: hypercholesterolemia and endothelial superoxide production. Harrison DG (2014) J Clin Invest 124: 473-5 Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Doughan AK, Harrison DG, Dikalov SI (2008) Circ Res 102: 488-96 GRIK5 Genetically Regulated Expression Associated with Eye and Vascular Phenomes: Discovery through Iteration among Biobanks, Electronic Health Records, and Zebrafish. Unlu G, Gamazon ER, Qi X, Levic DS, Bastarache L, Denny JC, Roden DM, Mayzus I, Breyer M, Zhong X, Konkashbaev AI, Rzhetsky A, Knapik EW, Cox NJ (2019) Am J Hum Genet 104: 503-519 Update in Pulmonary Vascular Disease 2016 and 2017. Brittain EL, Thennapan T, Maron BA, Chan SY, Austin ED, Spiekerkoetter E, Bogaard HJ, Guignabert C, Paulin R, Machado RF, Yu PB (2018) Am J Respir Crit Care Med 198: 13-23 A Pkd1-Fbn1 genetic interaction implicates TGF-β signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney disease. Liu D, Wang CJ, Judge DP, Halushka MK, Ni J, Habashi JP, Moslehi J, Bedja D, Gabrielson KL, Xu H, Qian F, Huso D, Dietz HC, Germino GG, Watnick T (2014) J Am Soc Nephrol 25: 81-91 BMP signaling in vascular development and disease. Lowery JW, de Caestecker MP (2010) Cytokine Growth Factor Rev 21: 287-98 Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury. Luther JM, Luo P, Wang Z, Cohen SE, Kim HS, Fogo AB, Brown NJ (2012) Kidney Int 82: 643-51 Role of vascular oxidative stress in obesity and metabolic syndrome. Youn JY, Siu KL, Lob HE, Itani H, Harrison DG, Cai H (2014) Diabetes 63: 2344-55 Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease. Pandey AK, Singhi EK, Arroyo JP, Ikizler TA, Gould ER, Brown J, Beckman JA, Harrison DG, Moslehi J (2018) Hypertension 71: e1-e8 Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ, Harrison DG (2010) Hypertension 55: 500-7 S-Adenosylhomocysteine: a better indicator of vascular disease than homocysteine? Wagner C, Koury MJ (2007) Am J Clin Nutr 86: 1581-5 EIF2AK4 mutations in pulmonary capillary hemangiomatosis. Best DH, Sumner KL, Austin ED, Chung WK, Brown LM, Borczuk AC, Rosenzweig EB, Bayrak-Toydemir P, Mao R, Cahill BC, Tazelaar HD, Leslie KO, Hemnes AR, Robbins IM, Elliott CG (2014) Chest 145: 231-236 Biomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated platelets. Zhu J, Xue J, Guo Z, Zhang L, Marchant RE (2007) Bioconjug Chem 18: 1366-9 Matrix metalloproteinases and cellular motility in development and disease. VanSaun MN, Matrisian LM (2006) Birth Defects Res C Embryo Today 78: 69-79 Plasma S-adenosylhomocysteine versus homocysteine as a marker for vascular disease. Wagner C, Koury MJ (2008) J Nutr 138: 980; author reply 981 Urinary cysteinyl leukotriene E(4) is associated with increased risk for pain and acute chest syndrome in adults with sickle cell disease. Field JJ, Krings J, White NL, Yan Y, Blinder MA, Strunk RC, Debaun MR (2009) Am J Hematol 84: 158-60 VHL and PTEN loss coordinate to promote mouse liver vascular lesions. Chen S, Sanford CA, Sun J, Choi V, Van Dyke T, Samulski RJ, Rathmell WK (2010) Angiogenesis 13: 59-69 Association of circulating sclerostin with vascular calcification in Afro-Caribbean men. Kuipers AL, Miljkovic I, Carr JJ, Terry JG, Nestlerode CS, Ge Y, Bunker CH, Patrick AL, Zmuda JM (2015) Atherosclerosis 239: 218-23 Free hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanism. Buehler PW, Baek JH, Lisk C, Connor I, Sullivan T, Kominsky D, Majka S, Stenmark KR, Nozik-Grayck E, Bonaventura J, Irwin DC (2012) Am J Physiol Lung Cell Mol Physiol 303: L312-26 Matrix metalloproteinases as valid clinical targets. Fingleton B (2007) Curr Pharm Des 13: 333-46 Normal and pathophysiologic considerations of endothelial regulation of vascular tone and their relevance to nitrate therapy. Harrison DG, Kurz MA, Quillen JE, Sellke FW, Mügge A (1992) Am J Cardiol 70: 11B-17B Endothelin: potential role in development and disease. Kon V, Fogo A (1993) Pediatr Nephrol 7: 876-80 Quantitative blood flow measurements with cine phase-contrast MR imaging of subjects at rest and after exercise to assess peripheral vascular disease. Pena CS, McCauley TR, Price TB, Sumpio B, Gusberg RJ, Gore JC (1996) AJR Am J Roentgenol 167: 153-7 Vascular trauma as a result of therapeutic procedures for the treatment of malignancy. Myers SI, Harward TR, Putnam JB, Frazier OH (1991) J Vasc Surg 14: 314-9 Alterations in colonic mucosal vessels in patients with cirrhosis and noncirrhotic portal hypertension. Lamps LW, Hunt CM, Green A, Gray GF, Washington K (1998) Hum Pathol 29: 527-35 Heterogeneity in vascular smooth muscle cell embryonic origin in relation to adult structure, physiology, and disease. Pfaltzgraff ER, Bader DM (2015) Dev Dyn 244: 410-6 Oxidative stress produced with cell migration increases synthetic phenotype of vascular smooth muscle cells. Sung HJ, Eskin SG, Sakurai Y, Yee A, Kataoka N, McIntire LV (2005) Ann Biomed Eng 33: 1546-54 Long-term silastic catheters and chest pain. Passaro ME, Steiger E, Curtas S, Seidner DL (1994) JPEN J Parenter Enteral Nutr 18: 240-2 Relationships between Cognitive Performance, Neuroimaging and Vascular Disease: The DHS-MIND Study. Hsu FC, Raffield LM, Hugenschmidt CE, Cox A, Xu J, Carr JJ, Freedman BI, Maldjian JA, Williamson JD, Bowden DW (2015) Neuroepidemiology 45: 1-11 Determination of inferior vena cava diameter in the angiography suite: comparison of three common methods. Brown DB, Labuski MR, Cardella JF, Singh H, Waybill PN (1999) J Vasc Interv Radiol 10: 143-7
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.